Search tool

Displaying 831 - 840 of 994

EMCDDA standard protocol to collect data and report figures for the key indicator drug-related deaths (DRD-Standard, version 3.0)

This is the DRD-Standard, the current protocol for the EMCDDA's drug-related deaths (DRD) indicator, one of five key epidemiological indicators used by the EMCDDA for the collection and interpretaion of harmonised, good...

Handbook for surveys on drug use among the general population

The Handbook for surveys on drug use among the general population is intended to be a reference toolbox for everyone planning, organising or executing a survey about drug use among the general...

Co-ordination of the implementation of the EMCDDA standard guidelines on the drug-related deaths indicator in the EU Member States, and the collection and analysis of information on drug-related deaths

This is the final report for an EMCDDA project carried out with the assistance of the Trimbos Institute, and in collaboration with Eurostat and WHO, to develop and test guidelines for ICD...

Drugnet Europe 36

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...

DRID protocol draft

This is a draft version of the protocol for the drug-related infectious diseases epidemiological indicator, one of five key indicators used by the EMCDDA to monitor the drug situation in Europe.

Prosecution of drug users in Europe — varying pathways to similar objectives

Researching and analysing the responses of the criminal-justice systems to drug offenders throughout Europe is one of the EMCDDA’s priorities. This study is the result of a decision taken by the EMCDDA’s...

Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs

Since the mid-1990s, GHB – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Some EU countries have reported worries over GHB’s surreptitious...

Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs

Since the mid-1990s, ketamine – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Concern over ketamine centres on its unpredictability in producing...

Measuring prevalence and incidence of drug use

Reducing the prevalence of drug use through prevention is a key feature of many policies at local, national and international levels. The first target of the European Union drugs strategy (2000–04) is...

General report of activities 2001

The General report of activities is an annual publication providing a detailed progress report of the EMCDDA's activities over a 12-month period. Published every spring, it catalogues the Centre's achievements in each...